O

Opsin Biotherapeutics, Inc.

1 employees

Opsin Biotherapeutics develops a pipeline of opsin-based gene therapies for pain management

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Life Science
Therapeutics
Medical Device
Genetics

Funding rounds raised

Total raised

$328K

from 2 investors over 2 rounds

O

Opsin Biotherapeutics, Inc. raised $328K on July 27, 2023

Investors: National Institutes of Health and National Institute of Neurological Disorders and Stroke (NINDS)

FAQ